Imagion Biosystems Limited (ASX: $IBX) has been reinstated to trading on the ASX following the lodgement of its Annual Report for the period ending 31 December 2023 and the release of an announcement regarding the appointment of a director.
We are pleased to announce the reinstatement of Imagion Biosystems to ASX trading. The lifting of the trading suspension signifies our commitment to transparency and timely disclosure of information to our shareholders and the market. We believe that the release of our Annual Report and the appointment of a new director will provide valuable insights into our performance and governance, further strengthening our position in the market.
Imagion Biosystems (ASX: $IBX) has successfully reinstated trading on the ASX following the lodgement of its Annual Report and the announcement of a new director. The company's proactive approach to compliance and governance is evident through the prompt release of these key updates. Looking ahead, Imagion Biosystems remains focused on delivering value to its shareholders and maintaining transparent communication. The reinstatement to quotation reflects the company's commitment to upholding market integrity and providing stakeholders with essential information for informed decision-making.